Prof. Dr. Samuel Huber’s
background is in the field of gastroenterology/immunobiology. He graduated in
April 2006 and obtained the Board Certification for Medicine. He carried out his
residency in the Department of Gastroenterology, University Medical Center
Hamburg–Eppendorf, Germany (chairman, Prof. A.W. Lohse). From 2008 to 2012, he
carried out his postdoctoral training at Richard A. Flavell’s lab in the Department of
Immunobiology, School of Medicine, Yale University, USA. Currently, he is
leading the Section of Molecular Gastroenterology and Immunology at the I.
Medical Department, University Medical Center Hamburg–Eppendorf, Germany. The
main focus of the lab is to study the mechanism controlling the homeostasis in
the intestine to identify new therapeutic targets for the treatment of
inflammatory bowel disease and colorectal cancer.
Prof. Dr. Samuel Huber’s
background is in the field of gastroenterology/immunobiology. He graduated in
April 2006 and obtained the Board Certification for Medicine. He carried out his
residency in the Department of Gastroenterology, University Medical Center
Hamburg–Eppendorf, Germany (chairman, Prof. A.W. Lohse). From 2008 to 2012, he
carried out his postdoctoral training at Richard A. Flavell’s lab in the Department of
Immunobiology, School of Medicine, Yale University, USA. Currently, he is
leading the Section of Molecular Gastroenterology and Immunology at the I.
Medical Department, University Medical Center Hamburg–Eppendorf, Germany. The
main focus of the lab is to study the mechanism controlling the homeostasis in
the intestine to identify new therapeutic targets for the treatment of
inflammatory bowel disease and colorectal cancer.